Cerebrolysin is a neuropeptide preparation manufactured by Everpharma and widely studied in neurological research. It contains a mixture of low‑molecular‑weight neuropeptides and free amino acids derived through controlled enzymatic processing. Research models explore Cerebrolysin for its potential influence on neuroprotection, synaptic plasticity, neuronal repair mechanisms, and neurotrophic signaling pathways.

Research Focus

• Studied for neuroprotective signaling in neuronal tissue
• Explored for synaptic plasticity and memory‑related pathways
• Investigated in models of neurodegeneration and cognitive decline
• Research interest in neuronal repair and neurotrophic activity
• Examined for mitochondrial and metabolic support in brain cells

Product Specifications

• Manufacturer: Everpharma
• Form: Sterile injectable ampoules
• Concentration: 215.2 mg/mL
• Ampoule size: 10 mL
• Pack size: 5 ampoules
• Total volume: 50 mL
• Storage: Store protected from light according to manufacturer guidance

Identity Basics

• Compound: Cerebrolysin neuropeptide complex
• Source: Porcine brain‑derived peptide fraction
• Peptide size range: Low molecular weight neuropeptides and amino acids
• CAS: Not assigned (biological peptide mixture)

Selected Research

• https://pubmed.ncbi.nlm.nih.gov/18797190/
• https://pubmed.ncbi.nlm.nih.gov/22673794/
• https://pubmed.ncbi.nlm.nih.gov/32004603/

⚠️ Disclaimer

• This product is intended for laboratory research use only.

• Not for human or veterinary use.

• Not approved for diagnostic, therapeutic, or medical applications.

• Handle using appropriate laboratory safety procedures and personal protective equipment.